Form 4 filed by Blume-Jensen Peter
Blume-Jensen Peter filed this Form 4 on ACRV (Acrivon Therapeutics, Inc.) with 2 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-19 21:38:20 UTC.
- Accession
- 0000905148-26-005050
- Filer
- CIK 1950499
- Filed
- 2026-11-19
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: ACRV · Acrivon Therapeutics, Inc. (CIK 1781174)
- Blume-Jensen Peter director, officer (President and CEO)
- Masson Kristina director, officer (EVP - Business Operations)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-11-17 | S sold | -1,276 | $1.45 | 2,228,776 | D |
| Common Stock | 2026-11-17 | S sold | -504 | $1.45 | 385,355 | I See Footnote |